Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-029904

SVP & General Counsel sold 3,136 shares at $3.95 ($12,387)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Wilson Mark Andrew SVP & General Counsel 2022-05-16 Sale −3,136 $3.95 $12,387 117,939 D
Open-market sales · 3,136 sh · avg $3.95 · $12,387
Loading xslF345X03/doc4.xml…